Related references
Note: Only part of the references are listed.A review of image-guided intensity-modulated radiotherapy for spinal tumors
Yoshiya Yamada et al.
NEUROSURGERY (2007)
Objective criteria for successful transsphenoidal removal of suprasellar nonfunctioning pituitary adenomas. A prospective study
J. Honegger et al.
ACTA NEUROCHIRURGICA (2007)
Non-functioning pituitary adenoma database:: a useful resource to improve the clinical management of pituitary tumors
Emanuele Ferrante et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2006)
Pathobiology of pituitary adenomas and carcinomas
Bernd W. Scheithauer et al.
NEUROSURGERY (2006)
Histopathologic assessment of hot-spot microvessel density and vascular patterns in glioblastoma: Poor observer agreement limits clinical utility as prognostic factors - A translational research project of the European Organization for Research and Treatment of Cancer Brain Tumor Group
Matthias Preusser et al.
CANCER (2006)
Observation alone after transsphenoidal surgery for nonfunctioning pituitary macroadenoma
OM Dekkers et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Magnetic resonance imaging and biological markers in pituitary adenomas with invasion of the cavernous sinus space
LX Pan et al.
JOURNAL OF NEURO-ONCOLOGY (2005)
Postoperative treatment of clinically nonfunctioning pituitary adenomas with dopamine agonists decreases tumour remnant growth
Y Greenman et al.
CLINICAL ENDOCRINOLOGY (2005)
Results of transsphenoidal surgery in a large series of patients with pituitary adenoma
P Mortini et al.
NEUROSURGERY (2005)
Measurement of Ki-67 antigen in 159 pituitary adenomas using the MIB-1 monoclonal antibody
CB Pizarro et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2004)
Multiregional sampling reveals a homogenous distribution of Ki-67 proliferation rate in pituitary adenomas
S Wolfsberger et al.
ACTA NEUROCHIRURGICA (2004)
Prolactinoma
JA Schlechte
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Expression of Ki-67 antigen in nonfunctioning pituitary adenomas:: correlation with growth velocity and invasiveness
J Honegger et al.
JOURNAL OF NEUROSURGERY (2003)
Postoperative surveillance of clinically nonfunctioning pituitary macroadenomas: markers of tumour quiescence and regrowth
Y Greenman et al.
CLINICAL ENDOCRINOLOGY (2003)
Growth pattern and rate in residual nonfunctioning pituitary adenomas: correlations among tumor volume doubling time, patient age, and MIB-1 index
Y Tanaka et al.
JOURNAL OF NEUROSURGERY (2003)
A critical reappraisal of MIB-1 labelling index significance in a large series of pituitary tumours: secreting versus non-secreting adenomas
ML Jaffrain-Rea et al.
ENDOCRINE-RELATED CANCER (2002)
MRI protocol technique in the optimal therapeutic strategy of non-functioning pituitary adenomas
G Soto-Ares et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2002)
Increased chromosomal imbalances in recurrent pituitary adenomas
CH Rickert et al.
ACTA NEUROPATHOLOGICA (2001)
Non-functioning pituitary adenomas: indications for postoperative radiotherapy
AC Woollons et al.
CLINICAL ENDOCRINOLOGY (2000)
Proliferation index of nonfunctioning pituitary adenomas: Correlations with clinical characteristics and long-term follow-up results
M Losa et al.
NEUROSURGERY (2000)
Surgical treatment of clinically nonsecreting pituitary adenomas in elderly patients
M Kurosaki et al.
NEUROSURGERY (2000)
Proliferation, vascular endothelial growth factor expression and cavernous sinus invasion in growth hormone secreting pituitary adenomas
T Iuchi et al.
ACTA NEUROCHIRURGICA (2000)
Cavernous sinus invasion and tumor proliferative potential of growth hormone-producing pituitary tumors
T Iuchi et al.
ENDOCRINE JOURNAL (2000)